|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2007-3-19
|
|
pubmed:abstractText |
Hidradenitis suppurativa (HS) is a chronic and debilitating disorder. Despite its significant prevalence, few reports of therapeutic studies are available. Recent case studies have reported the efficacy of antitumor necrosis factor monoclonal antibodies in treating the condition. In the study presented here, we assessed the safety and efficacy of infliximab in a series of patients with severe HS.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1097-6787
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
56
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
624-8
|
|
pubmed:meshHeading |
pubmed-meshheading:17240478-Adult,
pubmed-meshheading:17240478-Aged,
pubmed-meshheading:17240478-Antibodies, Monoclonal,
pubmed-meshheading:17240478-Cohort Studies,
pubmed-meshheading:17240478-Dermatologic Agents,
pubmed-meshheading:17240478-Dose-Response Relationship, Drug,
pubmed-meshheading:17240478-Drug Administration Schedule,
pubmed-meshheading:17240478-Female,
pubmed-meshheading:17240478-Hidradenitis Suppurativa,
pubmed-meshheading:17240478-Humans,
pubmed-meshheading:17240478-Infusions, Intravenous,
pubmed-meshheading:17240478-Male,
pubmed-meshheading:17240478-Middle Aged,
pubmed-meshheading:17240478-Patient Satisfaction,
pubmed-meshheading:17240478-Prognosis,
pubmed-meshheading:17240478-Quality of Life,
pubmed-meshheading:17240478-Risk Assessment,
pubmed-meshheading:17240478-Sampling Studies,
pubmed-meshheading:17240478-Severity of Illness Index,
pubmed-meshheading:17240478-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patients.
|
|
pubmed:affiliation |
Department of Dermatology, Hospital Saint-Antoine, Paris, France. laurence.fardet@sat.aphp.fr
|
|
pubmed:publicationType |
Journal Article
|
